Clinical Trial Detail

NCT ID NCT01606878
Title Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group

Advanced Solid Tumor

anaplastic large cell lymphoma


Dexamethasone + Doxorubicin + Vincristine Sulfate

Cyclophosphamide + Topotecan


Age Groups: child

No variant requirements are available.